Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics

• Published in: Frontiers in pharmacology Vol. 12; p. 688227
• Main Authors: Pushparaj, Peter Natesan, Abdulkareem, Angham Abdulrahman, Naseer, Muhammad Imran
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 31.08.2021
• Subjects: bronchial epithelium; cerebrospinal fluid; COVID-19; Neuro-COVID; Pharmacology; RNA sequencing; SARS-CoV-2; COVID-19; RNA sequencing; SARS-CoV-2; therapeutics; Neuro-COVID; cerebrospinal fluid; next-generation knowledge discovery platforms; bronchial epithelium

SARS-CoV-2 is the causative agent for coronavirus disease-19 (COVID-19) and belongs to the family Coronaviridae that causes sickness varying from the common cold to more severe illnesses such as severe acute respiratory syndrome, sudden stroke, neurological complications (Neuro-COVID), multiple orga...